| Pharmaceutical Information |
| Drug Name |
Vidarabine monohydrate |
| Drug ID |
BADD_D02354 |
| Description |
A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus. |
| Indications and Usage |
For treatment of chickenpox - varicella, herpes zoster and herpes simplex |
| Marketing Status |
approved; investigational |
| ATC Code |
S01AD06; J05AB03 |
| DrugBank ID |
DB00194
|
| KEGG ID |
D00406
|
| MeSH ID |
D014740
|
| PubChem ID |
32326
|
| TTD Drug ID |
D0NI0C
|
| NDC Product Code |
Not Available |
| UNII |
FA2DM6879K
|
| Synonyms |
Vidarabine | beta-Ara A | beta Ara A | Adenine Arabinoside | Arabinoside, Adenine | alpha-D-Arabinofuranosyladenine | alpha D Arabinofuranosyladenine | Ara A | alpha-Ara A | alpha Ara A | Arabinofuranosyladenine | Arabinosyladenine | 9-beta-D-Arabinofuranosyladenine | 9 beta D Arabinofuranosyladenine | 9-beta-Arabinofuranosyladenine | 9 beta Arabinofuranosyladenine | Ara-A | Vira-A | Vira A | ViraA |
|
| Chemical Information |
| Molecular Formula |
C10H15N5O5 |
| CAS Registry Number |
24356-66-9 |
| SMILES |
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
